AÂ $4.8 million grant from the California Institute for Regenerative Medicine (CIRM) will support a research project hoping to move a…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
In a reversal, the U.S. Food and Drug Administration (FDA) has informed Reata Pharmaceuticals that it will not hold an…
A mutation in the gene SIRT6 is associated with less severe neurological symptoms and visual impairment among people with…
A new mouse model called YG8-800, which accurately captures key features of Friedreich’s ataxia such as neurological dysfunction and…
The Friedreich’s ataxia community wants to get people talking about ataxia — a group of disorders that affect co-ordination,…
Skin cells of people with Friedreich’s ataxia (FA) show dysregulated levels of fat molecules, including abnormal levels of a…
Note: This story was updated on Aug. 10, 2022, to add the U.S. Food and Drug Administration has extended…
Mutations that cause Friedreich’s ataxia lead to abnormalities in how nerve fibers grow and reduce their ability to repair…
Astrocytes, a type of support cell in the brain, showed metabolic defects and unusual pro-inflammatory activity that likely contributes to…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…